NeuroOne Medical Shares Are Trading Higher After the Company Reported a Year-over-year Increase in FY24 Annual Results and Issued Expectations for a Year-over-year Increase in Its FY25 Product Revenue Guidance.
NeuroOne Medical Shares Are Trading Higher After the Company Reported a Year-over-year Increase in FY24 Annual Results and Issued Expectations for a Year-over-year Increase in Its FY25 Product Revenue Guidance.
NeuroOne 醫療公司的股票在公司報告了2024財年年度業績同比增長，併發布了2025財年產品營業收入指導預期同比增長後，交易價格上漲。
NeuroOne Medical Shares Are Trading Higher After the Company Reported a Year-over-year Increase in FY24 Annual Results and Issued Expectations for a Year-over-year Increase in Its FY25 Product Revenue Guidance.
NeuroOne 醫療公司的股票在公司報告了2024財年年度業績同比增長，併發布了2025財年產品營業收入指導預期同比增長後，交易價格上漲。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。